CYPH — CYPHERPUNK TECHNOLOGIES INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1509745 ·
Last close
$1.90
Market Cap
$205.29M
52W High
$4.19
52W Low
$0.49
ADV30
13,688,971
Next earnings
2026-11-16
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 9,913,000 | 8,977,000 | 2,606,000 | 306,005,000 | 567,348,000 | 55,988,000 | 31,789,000 |
| Jun 2026 | 0 | — | -4,689,000 | 39,389,000 | 142,969,000 | 7,624,000 | 3,650,000 |
| Mar 2026 | 0 | — | -4,817,000 | -77,166,000 | 87,378,000 | 6,689,000 | 3,003,000 |
| Dec 2025 | 0 | — | -5,260,000 | 40,203,000 | 163,182,000 | 14,035,000 | 9,676,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-21,058,000
Investing CF
$-18,544,000
Financing CF
$126,071,000
CapEx
$-13,544,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.76
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-500,326,000
Inventory
—
Receivables
$129,387,000
ST Investments
—
EBIT TTM
$1,257,000
Pretax Income TTM
$1,233,000
Interest Exp TTM
$24,000
Analysts
1
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -36,697,000 | 4,822,000 | 163,182,000 | 9,676,000 | 153,506,000 | -43,902,000 |
| Dec 2024 | 0 | -70,057,000 | -67,555,000 | 49,124,000 | 14,076,000 | 35,048,000 | -60,299,000 |
| Dec 2023 | 0 | -85,940,000 | -81,414,000 | 72,825,000 | 12,684,000 | 60,141,000 | -43,753,000 |
| Dec 2022 | 0 | -54,712,000 | -54,596,000 | 70,353,000 | 11,487,000 | 58,866,000 | -49,044,000 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-877,000
OpCashFlow TTM
—
Assets (Latest)
$142,969,000
Forward EPS
$-0.09
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.50 · spot: $1.75 · call volume: 215 · put volume: 631
Expected Move to 2026-12-18:
±$0.62
(35.43%) —
implied range
$1.13 –
$2.37
· ATM straddle on $1.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | $201.25M | $20.51 | — |
| ACIU | AC Immune SA | $209.79M | $2.11 | — |
| VOGX | Vogenx, Inc. | $200.25M | $13.48 | — |
| NGEN | NERVGEN PHARMA CORP. | $210.74M | $1.96 | — |
| LAB | STANDARD BIOTOOLS INC. | $212.95M | $0.54 | — |
News headlines (Yahoo Finance, 1h cache)
Cypherpunk Technologies Inc. Q3 2026 Earnings Call Summary
2026-11-16 21:50 · Yahoo
Cypherpunk (CYPH) Q3 2026 Earnings Call Transcript
2026-11-16 20:45 · Yahoo
Cypherpunk Swings to $2.6 Million Operating Profit on Zcash Mining Launch, Resumes ZEC Purchases
2026-11-16 19:18 · Yahoo
Cypherpunk Technologies Q3 Earnings Call Highlights
2026-11-16 16:15 · Yahoo
Winklevoss Twins-Backed Cypherpunk Says Zcash Mining Is 'Nowhere Close' To Bitcoin, AI — Sees $10K Potential
2026-10-12 17:37 · Yahoo
Another Zcash ETF Is Coming: Winklevoss Twins File for 'WINK'
2026-10-06 18:42 · Yahoo
Winklevoss Zcash ETF Could Become the Second U.S. Spot ZEC Fund After Grayscale’s ZCSH
2026-10-06 16:45 · Yahoo
Winklevoss-Backed Cypherpunk Launches 'World's Largest' Zcash Mining Fleet
2026-08-19 09:31 · Yahoo
Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research
2026-08-12 11:00 · Yahoo
Winklevoss-Backed Zcash Treasury Plunges Nearly 40% on ZEC Privacy Bug Concerns
2026-06-05 15:49 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.